Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

USA - NASDAQ:DORM - US2582781009 - Common Stock

151.53 USD
-3.77 (-2.43%)
Last: 9/29/2025, 8:00:01 PM
151.53 USD
0 (0%)
After Hours: 9/29/2025, 8:00:01 PM
Fundamental Rating

7

DORM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. DORM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DORM has a decent growth rate and is not valued too expensively. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
In the past year DORM had a positive cash flow from operations.
Each year in the past 5 years DORM has been profitable.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of DORM (9.14%) is better than 96.30% of its industry peers.
Looking at the Return On Equity, with a value of 16.14%, DORM belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.70%, DORM belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 8.51%.
The last Return On Invested Capital (12.70%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROIC 12.7%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 10.83%, DORM belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
DORM's Profit Margin has improved in the last couple of years.
The Operating Margin of DORM (15.75%) is better than 98.77% of its industry peers.
In the last couple of years the Operating Margin of DORM has grown nicely.
Looking at the Gross Margin, with a value of 40.88%, DORM belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
The number of shares outstanding for DORM has been reduced compared to 1 year ago.
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
The debt/assets ratio for DORM has been reduced compared to a year ago.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 5.10. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.10, DORM belongs to the top of the industry, outperforming 86.42% of the companies in the same industry.
The Debt to FCF ratio of DORM is 3.31, which is a good value as it means it would take DORM, 3.31 years of fcf income to pay off all of its debts.
DORM has a Debt to FCF ratio of 3.31. This is amongst the best in the industry. DORM outperforms 91.36% of its industry peers.
DORM has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
DORM has a Debt to Equity ratio of 0.31. This is amongst the best in the industry. DORM outperforms 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Altman-Z 5.1
ROIC/WACC1.29
WACC9.85%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.74 indicates that DORM has no problem at all paying its short term obligations.
DORM has a Current ratio of 2.74. This is amongst the best in the industry. DORM outperforms 85.19% of its industry peers.
A Quick Ratio of 1.21 indicates that DORM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.21, DORM is in the better half of the industry, outperforming 71.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 1.21
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.49% over the past year.
DORM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.83% yearly.
DORM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%

3.2 Future

The Earnings Per Share is expected to grow by 7.80% on average over the next years.
DORM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.18% yearly.
EPS Next Y25.1%
EPS Next 2Y16.16%
EPS Next 3Y14.11%
EPS Next 5Y7.8%
Revenue Next Year8.58%
Revenue Next 2Y6.94%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

DORM is valuated rather expensively with a Price/Earnings ratio of 18.39.
Compared to the rest of the industry, the Price/Earnings ratio of DORM is on the same level as its industry peers.
DORM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.67.
DORM is valuated correctly with a Price/Forward Earnings ratio of 15.73.
Based on the Price/Forward Earnings ratio, DORM is valued a bit more expensive than the industry average as 60.49% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of DORM to the average of the S&P500 Index (23.13), we can say DORM is valued slightly cheaper.
Industry RankSector Rank
PE 18.39
Fwd PE 15.73
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM indicates a slightly more expensive valuation: DORM is more expensive than 70.37% of the companies listed in the same industry.
60.49% of the companies in the same industry are cheaper than DORM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.2
EV/EBITDA 13.37
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
DORM's earnings are expected to grow with 14.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)0.84
EPS Next 2Y16.16%
EPS Next 3Y14.11%

0

5. Dividend

5.1 Amount

DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (9/29/2025, 8:00:01 PM)

After market: 151.53 0 (0%)

151.53

-3.77 (-2.43%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners86.2%
Inst Owner Change1.83%
Ins Owners10.79%
Ins Owner Change0.28%
Market Cap4.63B
Analysts81.67
Price Target166.6 (9.95%)
Short Float %3.37%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.85%
Min EPS beat(2)11.58%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)20.79%
Min EPS beat(4)9.67%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)21.58%
EPS beat(12)7
Avg EPS beat(12)9.41%
EPS beat(16)8
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.34%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)0.63%
PT rev (1m)5.38%
PT rev (3m)12.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)34.58%
EPS NY rev (1m)3.2%
EPS NY rev (3m)12.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.44%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)3.65%
Valuation
Industry RankSector Rank
PE 18.39
Fwd PE 15.73
P/S 2.22
P/FCF 33.2
P/OCF 26.36
P/B 3.31
P/tB 6.73
EV/EBITDA 13.37
EPS(TTM)8.24
EY5.44%
EPS(NY)9.63
Fwd EY6.36%
FCF(TTM)4.56
FCFY3.01%
OCF(TTM)5.75
OCFY3.79%
SpS68.33
BVpS45.85
TBVpS22.52
PEG (NY)0.73
PEG (5Y)0.84
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROCE 16.84%
ROIC 12.7%
ROICexc 13.08%
ROICexgc 20.96%
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
FCFM 6.68%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Debt/EBITDA 1.12
Cap/Depr 64.28%
Cap/Sales 1.73%
Interest Coverage 10.99
Cash Conversion 45.61%
Profit Quality 61.66%
Current Ratio 2.74
Quick Ratio 1.21
Altman-Z 5.1
F-Score7
WACC9.85%
ROIC/WACC1.29
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
EPS Next Y25.1%
EPS Next 2Y16.16%
EPS Next 3Y14.11%
EPS Next 5Y7.8%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%
Revenue Next Year8.58%
Revenue Next 2Y6.94%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%
EBIT growth 1Y22.22%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year34.96%
EBIT Next 3Y9.66%
EBIT Next 5YN/A
FCF growth 1Y167.44%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y80.56%
OCF growth 3Y32.07%
OCF growth 5Y19.38%